Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 289-530-3 | CAS number: 89899-25-2
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1994
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 994
- Report date:
- 1994
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- adopted in May 12, 1981
- Deviations:
- no
- Principles of method if other than guideline:
- None
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- Data from a reliable in vivo test conducted before the enforcement of Commission Regulation (EU) 640/2012 of 06 July 2012 amending, for the purpose of its adaptation to technical progress, Regulation (EC) No. 440/2008 laying down test methods pursuant to Regulation (EC) No. 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) are available.Data from a reliable in vivo test conducted before the enforcement of Commission Regulation (EU) 640/2012 of 06 July 2012 amending, for the purpose of its adaptation to technical progress, Regulation (EC) No. 440/2008 laying down test methods pursuant to Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) are available.
Test material
- Reference substance name:
- Sodium [3-hydroxy-4-[(1-hydroxy-5-sulpho-2-naphthyl)azo]naphthalene-1-sulphonato(4-)]chromate(1-)
- EC Number:
- 289-530-3
- EC Name:
- Sodium [3-hydroxy-4-[(1-hydroxy-5-sulpho-2-naphthyl)azo]naphthalene-1-sulphonato(4-)]chromate(1-)
- Cas Number:
- 89899-25-2
- Molecular formula:
- C20H10CrN2O8S2.Na
- IUPAC Name:
- Sodium [3-(hydroxy-κO)-4-{[1-(hydroxy-κO)-5-sulfonaphthalen-2-yl]diazenyl-κN1}naphthalene-1-sulfonato(4-)]chromate(1-)
- Test material form:
- other: Solid; blue lumps
- Details on test material:
- None
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- other: Pirbright White Strain (Tif: DHP)
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: 316-417 g
- Housing: Housed individually in Macrolon cages (Type 3)
- Diet: Standard guinea pig pellets- NAFAG No. 845, Gossau SG, ad libitum
- Water: Fresh water, ad libitum
- Acclimation period: 1 week
SENSITIVITY OF STRAIN
- The sensitivity of the strain is checked once or twice a year with a known mild to moderate sensitiser, such as mercaptobenzothiazole,
hexyl cinnamic aldehyde or potassiumdichromate
ENVIRONMENTAL CONDITIONS
- Temperature: 22±3 °C
- Humidity: 30-70 %
- Photoperiod: 12 h light/12 h dark
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal
- Vehicle:
- physiological saline
- Concentration / amount:
- 5 %
- Day(s)/duration:
- Day 0
- Adequacy of induction:
- highest technically applicable concentration used
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: vaseline
- Concentration / amount:
- 50 %
- Day(s)/duration:
- Day 8
- Adequacy of induction:
- highest technically applicable concentration used
Challenge
- No.:
- #1
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: vaseline
- Concentration / amount:
- 10 %
- Day(s)/duration:
- Day 21
- Adequacy of challenge:
- highest non-irritant concentration
- No. of animals per dose:
- Main test: 10 control animals and 20 treated animals (10 males and 10 females).
- Details on study design:
- MAIN STUDY
A. INDUCTION EXPOSURE
The induction was a two-stage operation. First, intradermal injections (into the neck region); second, closed patch exposure over the injection sites one week later.
- First induction, intradermal injection: Three pairs of intradermal injections (0.1 mL per injection) were made simultaneously into the shaved neck of the animals as follows:
- adjuvant and saline (1:1)
- test substance in physiological saline
- test substance in the adjuvant/saline mixture
- Second induction, epidermal application: One week later test substance was incorporated in vaseline and applied on a filter paper patch to the neck of the animals (patch 2 x 4 cm2; occluded administration for 48 h).
Dose of application: Approximately 0.4 g paste of 50 % test substance in vaseline.
B. CHALLENGE EXPOSURE
Two weeks after the epidermal induction application the animals were tested on the flank with test substance in vaseline and the vehicle alone (patch 2 x 2 cm²; occluded administration for 24 h).
Dose of application: Approximately 0.2 g paste of 10 % test substance in vaseline
The concentrations of the test substance for the induction and challenge periods were determined on separate animals.
Control group: A control group was treated with adjuvant and the vehicle during the induction period. During the challenge period the group was treated with the vehicle as well as with the test substance (at least 10 animals) to control the maximum subirritant concentration of the test substance in adjuvant treated animals.
OBSERVATIONS:
Induction reactions
After the intradermal and the epidermal induction application irritant reactions are normally induced by the adjuvant and the high test article concentration. Because most of the reactions are treatment related and not compound related, the reactions are only described in special cases in the section of results.
Challenge reactions
Twenty four and forty eight hours after removing the dressings, the challenge reactions were graded according to the Draize scoring scale.
General
The body weight was recorded at start and end of the test. - Positive control substance(s):
- yes
- Remarks:
- 2-Mercaptobenzothiazole puriss
Results and discussion
- Positive control results:
- Not available
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- Inradermal induction: 5 %, Epidermal induction 50 %, Epidermal challenge 10 %
- No. with + reactions:
- 3
- Total no. in group:
- 20
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- Inradermal induction: 5 %, Epidermal induction 50 %, Epidermal challenge 10 %
- No. with + reactions:
- 4
- Total no. in group:
- 20
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 2-Mercaptobenzothiazole puriss- Inradermal induction: 5 %, Epidermal induction 50 %, Epidermal challenge 30 %
- No. with + reactions:
- 20
- Total no. in group:
- 20
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 2-Mercaptobenzothiazole puriss- Inradermal induction: 5 %, Epidermal induction 50 %, Epidermal challenge 30 %
- No. with + reactions:
- 20
- Total no. in group:
- 20
Any other information on results incl. tables
None
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- FAT 20290/B did not show a skin sensitizing (contact allergenic) potential in albino guinea pigs.
- Executive summary:
The skin sensitisation potential of FAT 20290/B was evaluated in a study conducted according to OECD Guideline 406. The Guinea pigs tested included 10 (5 males and 5 females) animals in control group, 20 (10 males and 10 females) in the test group. The test group received following test concentrations: intradermal induction: 5 %, epidermal induction 50 %, epidermal challenge 10 %.
Under the experimental conditions employed, 15% and 20% of the animals of the test group showed skin reactions 24 and 48 hours after removing the dressings, respectively. Hence, it can be concluded that FAT 20290/B did not show a skin sensitizing (contact allergenic) potential in albino guinea pigs.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
